Plitidepsin

Pricing Availability   Qty

Save 26% on Select RUO Reagents. See Details

Description: Potent protein synthesis inhibitor
Alternative Names: Dehydrodidemnin B,DDB
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (2)

Biological Activity for Plitidepsin

Plitidepsin (dehydrodidemnin B) is a potent inhibitor of protein synthesis, blocker of G1 and G2 phases in cell cycle and potent antiviral against SARS-CoV-2 in hACE2-293T, Vero E6 cells and models of pneumocyte-like cells (IC90 values are 0.88 nM, 1.76 nM and 3.14 nM, respectively). Plitidepsin also inhibits eukaryotic translation elongation factor 1 alpha 1 (eEF1A) (KD = 80 nM).

In vitro, it inhibits induction of ornithine decarboxylase (ODC), which is essential for cell transformation and proliferation.

In vivo, daily administration of Plitidepsin on mice affected by Ehrlich carcinoma duplicated the animal life-span and decreased the total number of tumor cells by 70-90%. Plitidepsin also reduces viral SARS-CoV-2 replication in the lungs (mouse).

It is recommended to prepare stock solutions in DMSO.

Technical Data for Plitidepsin

M. Wt 1110.36
Formula C57H87N7O15
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 137219-37-5
PubChem ID 9812534
InChI Key UUSZLLQJYRSZIS-LXNNNBEUSA-N
Smiles [H][C@@]12CCCN1C([C@](CC(C)C)(NC([C@H](C([C@H](C(C)C)OC(C[C@@H]([C@](NC([C@H]([C@H](OC([C@@H](N(C2=O)C)CC3=CC=C(C=C3)OC)=O)C)NC([C@H](N(C([C@@H]4CCCN4C(C(C)=O)=O)=O)C)CC(C)C)=O)=O)([C@H](CC)C)[H])O)=O)=O)C)=O)[H])=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for Plitidepsin

References are publications that support the biological activity of the product.

Urdiales et al (1996) Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Letters 102 31 PMID: 8603376

Losada et al (2016) Translation elongation factor eEF1A2 is a novel anticancer target for the marine natural product plitidepsin. Sci.Rep. 6 PMID: 27713531

White et al (2021) Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science 371 926 PMID: 33495306

Reuschl et al (2021) Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant. bioRxiv PMID: 33501437


If you know of a relevant reference for Plitidepsin, please let us know.

View Related Products by Product Action

View all DNA, RNA and Protein Synthesis Inhibitors

Keywords: Plitidepsin, Plitidepsin supplier, Plitidepsin, DDB, Dehydrodidemnin, B, Aplidin, potent, selective, inhibitor, inhibits, protein, synthesis, eEF1A, antiviral, SARS, COV, 2, Covid, virus, reduces, viral, replication, antitumor, anticancer, proliferation, ornithine, decarboxylase, lung, cells, Ehrlich, carcin, DNA,, RNA, and, Protein, Synthesis, COVID-19, Coronavirus, Cell, Cycle, Inhibitors, 7416, Tocris Bioscience

Citations for Plitidepsin

Citations are publications that use Tocris products.

Currently there are no citations for Plitidepsin. Do you know of a great paper that uses Plitidepsin from Tocris? Please let us know.

Reviews for Plitidepsin

There are currently no reviews for this product. Be the first to review Plitidepsin and earn rewards!

Have you used Plitidepsin?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cell Cycle and DNA Damage Research Product Guide

Cell Cycle and DNA Damage Research Product Guide

This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:

  • Cell Cycle and Mitosis
  • DNA Damage Repair
  • Targeted Protein Degradation
  • Ubiquitin Proteasome Pathway
  • Chemotherapy Targets
Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells